Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
LATEST POSTS
- 1
Shadow Cats: The Elusive Leopards Surviving Against Impossible Odds - 2Before trips to Mars, we need better protection from cosmic rays
- 3Toilet rats? Washington health officials warn of possible rodents in sewer systems after floods
- 4Journalist reported killed in the Gaza Strip
- 5Aid sent by ambulance to Ukraine front line
- The teen queen bee of 'Laguna Beach' is now a 'cringey' mom
- Floods, Landslides Triggered By Heavy Rain In Afghanistan Leave 77 Dead In 10 days, Authorities Say
- Get away from the Tedious Drudgery: Go into Business Today!
- Astronauts on the ISS watched NASA's historic Artemis 2 launch from space
- Online business Stages for Little Retailers
- NATO needs Ukraine's 'adaptation DNA' and an 'HOV lane' for new war tech, top commander says
- The 15 Most Motivating TED Discusses All Time
- Vote in favor of Your Number one kind of pie
- Vote in favor of your Favored Kind of Scarf
